Early test of combo diabetes drugs in healthy people
NCT ID NCT07158346
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tested how a new combination of two experimental drugs (L03RD1 and L03RD2) is processed by the body and whether it is safe. It involved 49 healthy adults aged 19-55. The goal was to measure drug levels in the blood and check for side effects, not to treat diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H plus Yangji Hostpital
Seoul, 08756, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your gut bacteria hold the key to protecting your kidneys?
- Muscle-Saving supplement may shield seniors from Weight-Loss drug side effect
- Can diabetes disrupt the Brain-Heart link?
- A scent of citrus: could bitter orange oil ease fatigue and aid sleep in diabetes?
- Gut bacteria swap may tame diabetes and thyroid disease
- A blood marker may reveal how well diabetes treatments are working